Pipeline
Oncology: TCR Bispecifics
Epitope Target
Target Discovery
Lead Identification
Lead Optimization
IND Enabling
Phase 1
Tumor Associated Antigen
NSCLC, HNSCC, Pancreatic, TNBC, Colorectal, Stomach, Bladder
Phase: IND Enabling
Viral Antigen
HNSCC, Cervical
Phase: Lead Optimization
Tumor Associated Antigen
NSCLC, Ovarian
Phase: Lead Identification
Tumor Associated Antigen
Prevalent Cancers
Phase: Target Discovery
Oncology: Cancer Vaccine
Epitope Target
Target Discovery
Lead Identification
Lead Optimization
IND Enabling
Phase 1
Multiple Shared Class l/ll
Lung Squamous Carcinoma
Phase: Lead Identification
Individualized Class l/ll
Melanoma
Phase: Target Discovery
Autoimmune Disease: Tolerizing Vaccines
Epitope Target
Target Discovery
Lead Identification
Lead Optimization
IND Enabling
Phase 1
Multiple Shared Class ll
Type 1 Diabetes
Phase: Lead Optimization
Multiple Shared Class ll
Undisclosed
Phase: Target Discovery
Multiple Shared Class ll
Undisclosed
Phase: Target Discovery
